THIMBLE POINT ACQUISITION-A (THMA) Stock News

USA - NASDAQ:THMA - Common Stock

9.3

+0.18 (+1.93%)

Last: 12/3/2021, 8:30:52 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

THMA Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Pear Therapeutics, Inc. - Mentions: PEAR

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company

4 years ago - By: Pear Therapeutics, Inc.

Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference

4 years ago - By: Pear Therapeutics, Inc.

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

4 years ago - By: Pear Therapeutics

Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance

4 years ago - By: Pear Therapeutics, Inc.

Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan

4 years ago - By: Pear Therapeutics, Inc.

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

4 years ago - By: Pear Therapeutics, Inc.

Pear Therapeutics to Participate in the BTIG Digital Health Forum

4 years ago - By: Benzinga - Mentions: SOFI PAE MAPS ASTR ...

November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch

4 years ago - By: Pear Therapeutics, Inc.

Pear and Thimble Point Announce Nominees to Board of Directors

4 years ago - By: Benzinga - Mentions: MSFT VPCB GM ROT ...

14 SPACs That Palantir Technologies Has Invested In Or Partnered

4 years ago - By: Purcell Julie & Lefkowitz LLP

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Thimble Point Acquisition Corp. for Potential Breaches of Fiduciary Duty By Its Board of Directors

4 years ago - By: Barron's - Mentions: PLTR QELL BLK ROT ...

Palantir Has Quietly Become a Major SPAC Investor

4 years ago - By: Pear Therapeutics, Inc.

Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics

5 years ago - By: Thimble Point Acquisition Corp.

Thimble Point Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering